FDA — authorised 30 September 2013
- Application: NDA204447
- Marketing authorisation holder: TAKEDA PHARMS USA
- Local brand name: TRINTELLIX
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Vortioxetine Hydrobromide Tablets in United States
FDA authorised Vortioxetine Hydrobromide Tablets on 30 September 2013
Marketing authorisation
Frequently asked questions
Is Vortioxetine Hydrobromide Tablets approved in United States?
Yes. FDA authorised it on 30 September 2013.
Who is the marketing authorisation holder for Vortioxetine Hydrobromide Tablets in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.